Login

Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ) 00:00:00

Share On Facebook Share On Twitter

Enzymatica presents positive in-vitro results | August 2023

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Nuclear Weapons: Cold War Deterrence and Modern Challenges|George Shultz
00:10:00
Exploring Agios' Pioneering Approach at the Intersection of Cancer Metabolism and Genomics | David Schenkein, CEO,Agios Pharmaceuticals Inc .
00:10:00
Securing Jalen Hurts' Financial Future: Key Advice for NFL Stars
00:10:00
“Convegno di Primavera: George Muzinich on Complementary Pension Systems and Economic Impact Amidst New Regulations” | George Muzinich
00:10:00
Doug Ramshaw Discusses Monera Alamos’ Low-Capex Gold Development Strategy and Strong Market Position
00:10:00
"A Message from Pennant Group CEO Brent Guerisoli: Inspiring insights on life-changing leadership."
00:10:00
Orion Minerals Highlights Strategic Investment and Development in South Africa
00:10:00
FPX Nickel: Advancing Baptist Nickel Project with Strategic Partner Sumitomo
00:10:00
Robert Isom at Skift Global Forum 2018: The Future of American Airlines | Robert Isom, CEO, American Airlines Group Inc.
00:10:00
Winston Marshall Discusses New Ventures and Life After Mumford & Sons|Winston Marshall, Professor, Robert Zellinger de Balkany
00:10:00
Disruptive Innovation in Investment Management: Unveiling the Jobs to be Done|David Taten,Partner,Teten Advisors, LLC
00:10:00
Guide to Buying Your Dream Home in Retirement | Dana Anspach, CEO , Sensible Money, LLC.

© 2017 - Neuhu+